Sickle Cell Trait refers to the heterozygous form of Sickle Cell Disease. Those who voluntarily donate blood and have sickle cell trait can produce hemoglobin S and A properly. Regardless of a person's genetic status, Regional Blood Transfusion Centres can locate willing blood do...
Open access
Research Article10.9734/jammr/2025/v37i115990
Background: Sickle cell trait (HbAS) donor blood, akin to normal hemoglobin (HbAA) blood, undergoes storage-induced hematological and biochemical changes that may impact its efficacy, safety, and viability. Detailed characterization of these changes in HbAS donors’ blood remains...
Open access
Research Article10.9734/jammr/2024/v36i105602
Background: Sickle cell disease (SCD) is a major inherited haemoglobin disorder and a leading cause of childhood morbidity and mortality in sub-Saharan Africa. Repeated blood transfusions, although life-saving, increase the risk of red blood cell (RBC) alloimmunization, complicat...
Open access
Research Article10.9734/jammr/2026/v38i86172
Blood donation-related adverse reactions (BDRARs) remain a key concern in transfusion medicine due to their potential impact on donor safety and retention. This study assessed the effects of donors’ education level, ABO/Rhesus blood groups, and time of donation on the occurrence...
Open access
Research Article10.9734/jammr/2026/v38i46123